Cord blood has opened a new gateway in the field of alternative medicine.  Even though the concept of cord blood has been around since 1983, the first ever successful cord blood transplant was conducted on a six year old boy, who was suffering from Fanconi’s Anemia in 1983. Since then umbilical cord blood has been used in numerous therapies and transplants successfully.

Cord blood banking is a process of collecting stem cells in which umbilical cord blood is clamped and cut after a baby is born. These stem cells are adaptable cells that have the ability to regenerate and regrow. For this quality, these stem cells are used in treating more than 80 diseases and disorders now. There are two types of cord blood banking: Private and Public.

In private cord blood banking, you can store your baby’s store blood by investing a small amount of money. In exchange, you would retain the sole ownership of the stem cells, derived from the cord blood. This is the reason that more and more parents are opting for private cord blood banking, so they can use the stem cells any time in the future. On the contrary, you donate your cord blood in a public cord blood bank. Once donated, you cannot claim it in the future. Stem cells stored in public cord blood banks are used primarily in researchers and medical studies.

Once you save your baby’s cord blood, the stem cells can be used to treat any member of the close family circuit. For example, if you save your younger child’s cord blood, the stem cells can be transplanted to your elder child. They can also be used to treat any disease or disorder in you or your partner.

And the amazing part is, there is no need to match the cells before the transplant unlike bone marrow transplants. In bone marrow transplants, doctors need to go for graft vs. host disease (GVHD) matching, just to ensure safety and stability of the transplant. With cord blood stem cells, doctors can do away with GVHD matching. Since umbilical cord blood stem cells are inborn in nature, they are adaptive to any circumstances. Therefore the chances of rejection are also minimal to zero.

Now let’s take a look at the diseases and disorders that can be treated with cord blood stem cells.

Researchers have proved that cord blood stem cells can treat many types of cancer such as lymphoma, leukemia, and autoimmune. Apart from that these stem cells are extremely useful in treating the aftereffects of stroke, diabetes, and spinal cord injuries. Disorders like autism, Parkinson’s disease and Alzheimer’s disease are also treated with cord blood stem cells. Patients treated with the stem cells have shown immense improvement in the first 6 months.

So, once you save your child’s umbilical cord blood with a private cord blood bank, you can not only safeguard your child’s future, but also protect your family. Even though there is a fee attached, but for a safer and worry-free future, it’s totally worth it.

The post The value of Cord Blood in Medicine today appeared first on Stem Cell Banking Guide and Pregnancy Tips For New Parents.

Meet Alysson Muotri, an autism researcher and a professor at UC San Diego. His research mostly revolves around autism and how stem cell therapy impacts the brain development. His study is based on pluripotent stem cells (iPSCs), collected from people with autism. The researchers in his team are using the stem cells to model the condition in a lab dish. His team is trying to point out the affected cells and at the same time, invent a potential drug to cure the disorder.

When asked about his research about autism, Dr. Muotri expressed his frustration about no available models to understand the disorder at the first place. His team is involved in making a mini brain, because he thinks less accessibility to the human brain is the main reason that there is no proper tool or model to treat autism.

He said, “As a neuroscientist studying autism, I was frustrated with the lack of a good experimental model to understand autism. All the previous models (animal, postmortem brain tissues, etc.) have serious experimental limitations. The inaccessibility of the human brain has blocked the progress of research on ASD for a long time. Cellular reprogramming allows us to transform easy-access cell types (such as skin, blood, dental pulp, etc.) into brain cells or even “mini-brains” in the lab.”

He also briefed about how this process works. As they will be able to capture the genome of the affected person, it will be easy for them to track early phases of his/her neurodevelopment. He elaborately explained the process, as he said, “This is crucial to study neurodevelopment disorders, such as ASD, because of the strong genetic factor underlying the pathology [the cause of a disease]. By comparing “mini-brains” between an ASD and neurotypical [non-ASD] groups, we can find anatomical and functional differences that might explain the clinical symptoms.”
While talking about his model, he mentioned that his team mainly uses genome editing techniques and reprogramming stem cells. The reprogramming stem cells are used to create organoids or mini brains. And the genome editing techniques help in generating 3D organoid models. These organoids grow into the mature brains in the lab. The process is quite similar to that of fetal brain, so the researchers can track the structure and development over time.

About this new model, he said, “This new model brings something novel to the table: the ability to experimentally test specific hypotheses in a human background. For example, we can ask if a specific genetic variant is causal for an autistic individual. Thus, we can edit the genome of that autistic individual, fixing target mutations in these mini-brains and check if now the fixed mini-brains will develop any abnormalities seen in ASD.”

He is, currently, running a clinical trial involving IGF-1, or insulin growth factor-1. He is very hopeful that a drug will soon be discovered to treat autism. He said, “I am a big enthusiastic fan of personalized treatments for ASD. While we continue to search for a treatment that could help a large fraction of ASD people, we also recognized that some cases might be easier than others depending on their genetic profile.”

With that, he assures that his team is also working on a tool to diagnosis autism. This would certainly help parents and doctors to initiate treatments and therapies at an early stage, even before the symptoms start to appear.

The post One Scientist’s Quest to Understand Autism Using Stem Cells appeared first on Stem Cell Banking Guide and Pregnancy Tips For New Parents.

What is autism? What makes autistic people different from others? What causes autism? There are hundreds of questions in people’s mind when it comes to this condition. What is it actually?

Autism is a mental condition that remains present from the early childhood days and lasts for a lifetime. It’s characterized by minor to major difficulties in social interaction and framing language abstract concepts. And the critical part is, it’s incurable. However, a new study shows that stem cell therapy may show great improvement in children with autism.

It’s the story of Gracie Gregory, one of the 25 autistic children who participated in the study at Duke University in Durham, North Carolina involving stem cells to tone down the issues associated with autism. The idea behind the research was to find out if a transfusion of the self-umbilical cord blood with the rare stem cells can cure autism or at least reduce the severity.

Gracie was diagnosed with autism at the age of 2. When Gracie’s mother first came to know about the research, she immediately enrolled her without knowing what to expect and what not to expect. Such was the difficulty; they were facing with their autistic child. There was a time when Gracie’s sister, Ryleigh was afraid of her because of her unmanageable behavior like hitting and kicking. But now that very Ryleigh thinks Gracie is “very sweet and kind.” And it only became possible after the stem cell therapy.

Gracie was on the mild to moderate scale of autism. During the trial, Gracie, then 5, started with the same symptoms like kicking, spitting, screaming and even hitting her therapists. It was almost impossible to make her sit at one place.

The results were beyond what Gracie’s parents were expecting! Her parents recollects how difficult their life was back then when managing her would take 75% of their daily life and now after the therapy she only consumes 10% of their daily time. When asked about rating her improvement on a scale of 1 to 10, her parents proudly rated 8/9.

She now attends regular school, plays with her sister, and enjoys life to the fullest, something that her parent would never have thought of.

According to her father, “We will say we don’t think it’s cured her. You still see some of the small idiosyncrasies that she does have. But again, I think it’s supercharged her learning curve. It’s pushed her to do things she normally wouldn’t do.” Her mother added, “She got better, and we’re just thankful for that — whether it be the stem cells or not. We’re just thankful for what changes have happened”.

Two thirds of the children, involved in the study showed great improvement. This is the results of the first phase of the study and a broader second level trail is on its way, which promises a long-term treatment for autistic children.

Skeptics are still saying that no matter what autism cannot be cured and there are quite a few unanswered questions that need to be addressed before going gaga over it. Even researchers at Duke acknowledge that the study is at a very early stage and still there is a long way to go. But for families like Gregorys, it’s a life-changing experience.

The post Stories of Hope – Cord Blood Stem Cells Offer Hope For Autism appeared first on Stem Cell Banking Guide and Pregnancy Tips For New Parents.

Researchers were wondering from ages as to what could be the actual cause of Huntington’s disease which causes involuntary jerky body movements disabling the victim to exhibit physical and mental coordination. The awkward bodily momentum gradually worsens after the initial unsteady gait putting the victim in jeopardy. Parental inheritance being the focal reason, this disease is hard to prevent and has been affecting millions of people globally without a documented cure. However, the available treatments reduce the severity of the symptoms and aid the victim in lessening the care giving requirements.

To enhance the quality of life of the global populace affected with Huntington’s disease, researchers are looking forward to get core advancement in finding an explicit medical solution. However, the extensive research to find the root cause of Huntington’s disease has enabled the researchers to get a key which can be a potential advancement in finding a generic solution to lessen the severity of the ailment. It is established that a mutant of the Huntington (mHTT) protein is the fundamental cause of the disease though the researchers are still unclear as to how it disturbs the brain cells’ function. As per the established findings of late, mHTT vitiates the cellular transport process adding to the neurotoxicity eventually resulting in loss of neurons.

Caused by an extended CAG repeat in the Huntington (HTT) gene, this neurodegenerative disease with mHTT plays pivotal role in disrupting the transport system of a cell which normally requires mobilizing multiple elements from its nucleus to the other parts and vice-versa. It has been pragmatically realized that mHTT creates aggregates in the central operations area that is in the nucleus preventing it from passing through the nuclear pores.  This pile up in the mHTT following the stagnation in the nuclear passages kills the brain cells by shutting them down.

The new fact discovered can drive the researchers to find out new ways to fix the cellular traffic jams there by aiding the process of finding new treatment methodologies for the Huntington’s disease. Although it is a fact that this step towards an advanced research in finding the cause for the disease is in the initial stage, the researchers are excited with their discovery as these findings are the stepping stones in conquering the Huntington’s disease along with encouraging the search for new therapeutic modules.

Biotech companies and pharmacy companies are looking forward to dwell on this very concept to capitalize it and bring into existence various therapies for biological processes. Hope they get abundant clues to prove the fact that early birds get quick worms in the course of their research. Ultimately, it is the millions of people who are affected with the Huntington’s disease who get the best of the research.

The post Cellular Traffic Jam Is The Culprit Behind Huntington’s Disease appeared first on Stem Cell Banking Guide and Pregnancy Tips For New Parents.

This is the story of Doug Oliver, who suffered from macular degeneration or progressive blindness for more than two years. His medical team conducted a stem cell treatment on him and now he has recovered his eyesight and is leading a healthy life.

Doug started losing his vision at the age of 32. When consulted with doctors, they told him that this was the result of macular degeneration and he would gradually lose his vision. Doctors did not give him any hope and said nothing could be done to regain his sight.

To make the situation worse for him, he met with an accident after the diagnosis, which made his stand in front of another devastating news. He might lose his vision completely. Some tests were done on him that revealed his vision was as 20/2000 in the left eye and 20/400 in the right eye.

However, having found out about his condition, Doug was not willing to give up. He was not ready to succumb to the prediction that his sight could not be cured. So, he started screening latest clinical studies, databases, and trials related to macular degeneration. This was the time when Doug discovered Dr. Jeffrey Weiss’s clinical trial with stem cells in order to treat macular degeneration.

Doug enrolled himself in the Florida-based trial in 2015. And only after two days of stem cell therapy, he started to feel a difference in his vision. The stem cell therapy involved extracting his own stem cells from his marrow of the hip bone. The stem cells then were injected directly into both of his retinas. Two days later, his vision showed an improvement to 20/40 in his left eye and 20/30 in the right eye.

The joy of seeing the world again in its full glory was evident in his confession that he made while he was going back home. He said, “I could see the boats and the little wake lines that you see from 30,000 feet. I acted like a 6-year-old and loved it.”[1]

Doug was an IT specialist and a social policy consultant. His job demanded a lot of traveling by car. During one of those drives, he realized that his vision was not as same as before. Moreover, the accident cost him his driving license as well, which eventually led him to lose his job. He was not only going through physical issues but also through a mental turmoil. An active person like him needed to rely on a monthly disability check. But stem cells helped him bounce back and how!

Doug has not only got his vision back, but he also gained his position back in the community. He said, “I went back to the DMV and got my license in Tennessee in December.”[2] He is currently in talks with Lamar Alexander, the Senate Health Committee Chairman, so his can share his experience and story with others. Doug’s story may also play a crucial role in passing the 21st Century Cures Act, which focuses on the advanced regenerative therapy and the required funding for clinical trials, similar to one he was a part of.

The post Stories of Hope: Cured Of Blindness: A Stem Cell Therapy Story appeared first on Stem Cell Banking Guide and Pregnancy Tips For New Parents.

Modern medical science has proved many old notions wrong. Our belief that the adult brain cannot grow new neurons, is one of them. Researchers now have proved that the stem cells, present in our brains can generate new neurons and the use of Prozac or any other anti-depressant drug may help in neurogenesis (the growth of new nervous tissue). The discovery has also led to new insights like how an adult brain functions and what it might take to treat brain-related conditions such as depression.

RIKEN institute researchers have developed a new and non-invasive technique to detect the generation of new neurons from the stem cells in the brain. Measuring new brain cells non-invasively was, however, a challenging process. Both the Magnetic resonance imaging (MRI) and the positron emission tomography (PET) scanning are risky and difficult to conduct and the signals, received are also non-definitive.  However, the RIKEN team has come up with the solution by adding proteins in the PET signals.

They used a clinically available drug in the PET process to block the transporter proteins. And the result was a clear neurogenesis signal. Yosky Kataoka, the lead of the team behind the study said, “This is a very interesting finding because it has been a long-time dream to find a noninvasive test that can give objective evidence of depression and simultaneously show whether drugs are working in a given patient.”

The study was conducted on rats. The PET technique involves injecting a small amount of a radioactive tracer to stick to a targeted molecule in tissues, so that the scientists can scan and track the gamma rays, emitting from that region. The rats were divided into two groups. Over the period of a month, the first group was given a stress hormone, corticosterone in order to induce a depression-like behavior. And the second group received both the corticosterone and the antidepressant drug, Prozac.

After they scanned the brains of the animals, they found out that the radioactivity was prominent enough to tell apart the differences between the damaging effects of the stress hormone and healing effects of the antidepressant. The PET scan signal helped the researchers to detect a decrease in neurogenesis in the first group of rats, who received only the stress hormone, whereas they found a recovery in neurogenesis in the second group of rats, who were given both the hormone and the drug.

The enhanced PET imaging method not only proved that the adult brain neurogenesis can be detected and measured, but it is also able to track the dynamic changes in the rate of the progress due to the antidepressants. The results confirmed that the first group, treated with the stress hormone, corticosterone, showed about 45% fewer newborn brain cells, compared to the untreated animals. However, the second group, who received both corticosterone and Prozac, displayed no such result.

Even though the experiment was entirely done on animals, the team is now eager to apply this non-invasive imaging technique to detect and measure depression in humans. Kataoka confirmed, “Since it is known that these same brain regions are involved in depression in the human brain, we would like to try this technique in the clinic and see whether it turns out to be effective in humans as well.”

The post Measuring Depression With Non-invasive Imaging of New Brain Cells appeared first on Stem Cell Banking Guide and Pregnancy Tips For New Parents.

As the science of stem cells took off in the 1970s when doctors realized that the stem cells found in the blood inside an umbilical cord could offer a much more secure substitute to bone marrow transplants that may find its way in the utilization of treating conditions such as leukaemia, lymphoma, and sickle cell anemia. This is so since cord blood is power packed with multipotent, self-renewing hematopoietic stem cells (HSCs), which are the forerunners to blood cells.

The process of extracting this cord blood immediately after birth and storing it in state-of-art laboratories in India and overseas for future use is now a convenient and affordable reality for many Indians, thanks to health companies like Cordlife India. In fact, Cordlife is the only private Cord Blood Bank in India to offer automated cord blood processing with Sepax2, a versatile patented Swiss technology. This advanced technology enables easy handling and safety of processing and aids in highly efficient and consistent cell recoveries.

Once the umbilical cord has been clamped from the newborn, the cord blood is collected from the umbilical cord vein attached to the placenta. Cord Blood extraction is not only a painless process for both mother and baby unlike bone marrow extraction, but there is a 60% higher chance of matching cord blood unit in the family vis-a-vis bone marrow. Cord Blood cells are mature, flexible and have more usage advantages than stem cells extracted from the bone marrow or umbilical blood.

After cord blood is extracted, Stem Cell Banks preserve the stem cells via Cryopreservation. Under various such methods of Cryopreservation, any damage to the stem cells caused by any enzymatic or chemical activities is prevented by cooling to very low temperatures, without further damage being triggered by the formation of ice during freezing.

Stored Cord Blood can now be available between days or weeks of processing for treatment. There is a low risk of complications when cord blood is applied for stem cell transplants and therapy since they have the ability to regenerate in the desired way.

Globally, an estimated 35,000 transplants have taken place where cord blood stem have been utilized to treat over eighty life-threatening ailments, including Alzheimer’s, Parkinson’s, bone marrow failures, genetic disorders, blood disorders and immune disorders. Several medical professionals are also researching cord blood as a potential cure for conditions that cannot be remedied presently. Umbilical Cord Blood banking is no more an option, but a necessity to secure a healthy future for the entire family.

For more details about – Why Banking Umbilical Cord Blood should be on your “To Do” List? – visit https://www.cordlifeindia.com

The post Why Banking Umbilical Cord Blood Should Be On Your “To Do” List? appeared first on Stem Cell Banking Guide and Pregnancy Tips For New Parents.